ClinConnect ClinConnect Logo
Search / Trial NCT06232226

Attention Deficit Hyperactivity Disorder

Launched by NANTES UNIVERSITY HOSPITAL · Jan 22, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Attention Deficit Disorder With Hyperactivity Addictive Disorders Neuropsychology Methylphenidate Atomoxetine Functional Impairment Symptoms

ClinConnect Summary

This clinical trial is looking at patients who have both Attention Deficit Hyperactivity Disorder (ADHD) and an addiction, such as substance use disorder or behavioral addiction. The goal is to collect important information about these patients over two visits: one when they first join the study and another after 12 months. The information gathered will help understand how these conditions affect each other and how best to treat them.

To be eligible for the trial, participants need to be at least 15 years and 3 months old and must have received a diagnosis of ADHD and an addiction within the last six weeks. They should also be new to treatment with a specific medication called MPH, which is commonly used to help manage ADHD. Participants will need to attend both visits, and they should be comfortable speaking and understanding French, as this is important for data collection. This study is an opportunity to contribute to research that could improve treatment for others facing similar challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria :
  • Patients aged over 15 years and 3 months
  • For whom a diagnosis of ADHD has been confirmed less than 6 weeks ago
  • For whom the diagnosis of one or more addictive disorder(s) (substance use disorder or behavioral addiction) has been confirmed
  • Meeting the indication for treatment with MPH according to European recommendations (Kooij et al., 2019)
  • For patients who can actually benefit from MPH: who have not yet started taking MPH
  • Social security affiliates
  • Exclusion Criteria :
  • Presenting disorders of higher cognitive functions (at the discretion of the referring clinician or the investigator making the inclusion), making data collection impossible
  • Presenting difficulties in reading or writing the French language making data collection impossible
  • Unable to commit to being available for the 2 visits planned as part of the cohort
  • Under guardianship or legal protection

About Nantes University Hospital

Nantes University Hospital, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific exploration with patient care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Nantes University Hospital aims to contribute to the development of effective therapies and interventions that enhance patient outcomes and overall public health.

Locations

Tours, , France

Nantes, Loire Atlantique, France

Brest, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported